Jun 2, 2026 08:02AM
Jun 2, 2026 08:00AM
May 18, 2026 06:43AM
May 15, 2026 11:45AM
Mar 18, 2026 05:21PM
Mar 18, 2026 04:00PM
Nov 10, 2025 04:15PM ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
Nov 6, 2025 11:00AM
Nov 6, 2025 11:00AM
Aug 12, 2025 05:52PM
Aug 12, 2025 04:01PM
Jul 15, 2025 07:30AM
Jul 15, 2025 07:30AM
Jul 8, 2025 07:00AM ProKidney reports positive phase 2 trial results for kidney disease therapy
Jul 8, 2025 07:00AM
May 12, 2025 05:08PM
May 12, 2025 04:15PM
Mar 17, 2025 07:30AM
Nov 12, 2024 07:36AM
Nov 12, 2024 07:30AM
Sep 3, 2024 07:31AM ProKidney Corp (PROK) Announces Strategic Updates to its Phase 3 Program
Sep 3, 2024 07:30AM
Aug 13, 2024 04:59AM
Aug 9, 2024 07:00AM
May 21, 2024 07:00AM
May 10, 2024 07:00AM
Mar 25, 2024 06:06AM
Mar 25, 2024 06:05AM ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
Mar 21, 2024 07:49PM
Nov 30, 2023 06:05AM
Nov 21, 2023 06:05AM
Nov 14, 2023 06:41AM
Nov 14, 2023 06:05AM
Nov 13, 2023 05:02PM
Nov 13, 2023 05:02PM ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates
Oct 30, 2023 04:12PM
Sep 5, 2023 06:05AM
Aug 10, 2023 04:14PM
Aug 10, 2023 04:10PM
Jul 18, 2023 06:05AM
Jul 17, 2023 06:05AM
Jun 13, 2023 12:05PM ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC
Jun 1, 2023 04:05PM
May 11, 2023 04:01PM
May 4, 2023 06:05AM
Mar 28, 2023 04:12PM
Mar 28, 2023 04:12PM
Mar 3, 2023 06:05AM
Jan 10, 2023 04:06PM ProKidney Corp (PROK) Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT
Jan 10, 2023 04:05PM

1,199,657 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All